Antibiotic Resistance in India: Drivers and Opportunities for Action

Ramanan Laxminarayan; Ranjit Roy Chaudhury

doi:10.1371/journal.pmed.1001974

Antibiotic Resistance in India: Drivers and Opportunities for Action

PLoS Med. 2016 Mar 2;13(3):e1001974. doi: 10.1371/journal.pmed.1001974. eCollection 2016 Mar.

Authors

Ramanan Laxminarayan^{1

2

3}, Ranjit Roy Chaudhury⁴

Affiliations

¹ Center for Disease Dynamics, Economics & Policy, Washington, D.C., United States of America.
² Princeton Environmental Institute, Princeton University, Princeton, New Jersey, United States of America.
³ Public Health Foundation of India, New Delhi, India.
⁴ Apollo Hospitals Educational and Research Foundation, New Delhi, India.

Abstract

Ramanan Laxminarayan and Ranjit Roy Chaudhury examine the factors encouraging the emergence of antibiotic resistance in India, the implications nationally and internationally, and what might be done to help.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animal Husbandry
Anti-Bacterial Agents / therapeutic use*
Carbapenems
Drug Resistance, Bacterial*
Environmental Pollution*
Fluoroquinolones
Fraud
Gram-Negative Bacteria
Health Services Accessibility
Humans
India
Nonprescription Drugs*
Prescription Drug Overuse*
Public Health*

Substances

Anti-Bacterial Agents
Carbapenems
Fluoroquinolones
Nonprescription Drugs

Grants and funding

Time spent on this paper was supported by the Global Antibiotic Resistance Partnership funded by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.